|
ZWINT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.818860E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.242800E-04 |
| Normal-vs-Stage2 |
3.771000E-01 |
| Normal-vs-Stage3 |
1.035760E-02 |
| Normal-vs-Stage4 |
1.347350E-01 |
| Stage1-vs-Stage2 |
1.011000E-01 |
| Stage1-vs-Stage3 |
8.367800E-01 |
| Stage1-vs-Stage4 |
4.263800E-01 |
| Stage2-vs-Stage3 |
1.797970E-01 |
| Stage2-vs-Stage4 |
4.929600E-01 |
| Stage3-vs-Stage4 |
5.771200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.157180E-03 |
| Normal-vs-AfricanAmerican |
1.373970E-01 |
| Normal-vs-Asian |
6.313800E-02 |
| Caucasian-vs-AfricanAmerican |
8.760200E-01 |
| Caucasian-vs-Asian |
4.697000E-01 |
| AfricanAmerican-vs-Asian |
6.445600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.593500E-02 |
| Normal-vs-Female |
1.522410E-03 |
| Male-vs-Female |
5.751200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.420400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.800300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.442400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.804030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.531600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.517600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.211400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.270200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.237800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.787600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.098800E-01 |
| Classical-VS-Follicular |
4.645600E-01 |
| Classical-VS-Other |
9.434600E-01 |
| Classical-VS-Normal |
1.515480E-03 |
| Tall-VS-Follicular |
8.038100E-02 |
| Tall-VS-Other |
7.870200E-01 |
| Tall-VS-Normal |
4.594600E-04 |
| Follicular-VS-Other |
8.383600E-01 |
| Follicular-VS-Normal |
7.024300E-02 |
| Other-VS-Normal |
5.354600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.783900E-03 |
| Normal-vs-N1 |
1.022780E-01 |
| N0-vs-N1 |
6.445800E-01 |
|
|
